Inventory has been gradually restoring post GST roll-out from very low levels,and the streamlining of supply-side system is leading to sustained better off-take in domestic formulation (DF). A JP is building a facility at Guwahati to reduce outsourcing, and thus, ensure better administrative control/compliance and also enjoy tax benefits. Although only five ANDAs were filed for the US market in 1HFY18, the company has maintained its guidance of 10-15 filings over FY18. After declining sharply in 2QFY18, US sales are expected to pick up, l ed by the launch of recently approved products and increased traction in existing products.AJP has been selected as a supplier in the institutional anti-malaria business from the Global Fund, but is yet to obtain orders. The company maintained its guidance of 15-20 % YoY lower sales in FY18 due to lower allocation from the Global Fund.